43377294034

A First Class stamp http://planetsuzy.fun planetsuzy hd
“Edoxaban will face intense competition when it reachesthe market,” Yasuhiro Nakazawa, a health-care analyst at SMBCNikko in Tokyo, said in a telephone interview before the studyresults were published. “Patients and doctors don’t seem toswitch brands once they are on medication, so it’ll be a slowstart for Daiichi Sankyo.”